Brian Gallagher
InvestorPartner at SR One Capital Management
Boston, Massachusetts
Writes $15M – $30M checks · typically $22.5M
Find your path to Brian
377 people in our graph share verified history with Brian — schools, employers, funds. One of them is your warm intro.
Quentin ClarkunlockedBrian: together at University of Massachusetts Amherst (1990–1992)
.png)
×5Brian: together at GlaxoSmithKline
×5Brian: together at University of Michigan
Brian: together at SR One Capital Management
Experience
- Zenon BiotechChairman of the Boardcurrent2025 — present
- Cumulus OncologyChairman of the Boardcurrent2024 — present
- Slate BioDirector Board of Directorscurrent2022 — present
- DreaventVenture Partnercurrent2024 — present
- Michigan Biomedical Venture FundInvestment Advisory Board Membercurrent2016 — present
- Biogene Therapeutics Inc.Corporate Advisory Boardcurrent2024 — present
- Latent BioCorporate Advisory Boardcurrent2025 — present
- University of MichiganExternal Advisory Board, Michigan Drug Discoverycurrent2020 — present
- eFFECTOR Therapeutics, Inc.Chairman of the Board2020 — 2024
- Trekk Venture PartnersManaging Partner and Co-Founder2022 — 2024Boston, Massachusetts, United States
- Q32 Bio Inc.Board of Directors2020 — 2022
- AbingworthPartner2018 — 2022Boston
- Translate Bio, A Sanofi CompanyBoard of Directors2011 — 2019
- Princeps TherapeuticsBoard of Directors and Co-Founder2017 — 2018
- Navitor PharmaceuticalsBoard of Directors2014 — 2018
- CalciMedicaBoard of Directors2013 — 2018
- Nimbus TherapeuticsBoard of Directors2013 — 2018
- SR OnePartner2010 — 2018Cambridge, MA
- GlaxoSmithKlineVice President, Business Investments2010 — 2018Cambridge, MA
- Constellation Pharmaceuticals, A MorphoSys CompanyBoard Observer2010 — 2018
- Aileron TherapeuticsBoard of Directors2010 — 2018
- River Vision Development Corp.Board of Directors2012 — 2017
- Spero TherapeuticsBoard Observer2013 — 2015
- Dicerna Pharmaceuticals, Inc.Board Observer2010 — 2014
- SpringLeaf TherapeuticsBoard of Directors2011 — 2013
- Sirtris PharmaceuticalsSenior Director of Corporate Development2009 — 2010Cambridge, MA
- Sirtris PharmaceuticalsDirector of Corporate Development2008 — 2009Cambridge, MA
- Alantos Pharmaceuticals Inc.Associate Director, Medicinal Chemistry2005 — 2008Cambridge, MA
- Eisai USProject Leader / Senior Research Investigator1998 — 2005Andover, MA
Skills & more
Drug Discovery68Biotechnology67Lifesciences17Pharmaceutical Industry31Drug Development31Technology Transfer32Clinical Development13Oncology11Commercialization23Medicinal Chemistry7Organic Chemistry7Biopharmaceuticals16
+12 more
Venture CapitalVenture FinancingBusiness DevelopmentLicensingBoard of Director experiencecompany creationEntrepreneurshipLife Science IndustryBusiness OperationsR&DIntellectual PropertyChemistryFrom Brian's professional profile.
Colleagues at SR One Capital Management
Alicia Hasson
Executive Assistant at SR One Capital Management
Amit Mehta
Venture Partner - US Investments at SR One Capital Management
Amit Shah
Principal at SR One Capital Management
Ann Ng
Finance Director at SR One Capital Management
Briana Wilson
Senior Administrative Assistant at SR One Capital Management
Catalina Kazi
Legal & Compliance Counsel at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management
Dalton Stites
Portfolio Program Analyst at TDK Ventures
Network3
Amit Shah
Principal at SR One Capital Management
Chris Chai
Operating Partner - Portfolio Capital Raising at SR One Capital Management
Jake Nunn
Partner at SR One Capital Management
Investors connected to Brian in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Brian Gallagher?
- Partner at SR One Capital Management
- Where does Brian Gallagher work?
- Brian Gallagher is Partner at SR One Capital Management.
- What check size does Brian Gallagher write?
- Brian Gallagher typically writes checks of $15M – $30M.
- Where did Brian Gallagher go to school?
- Brian Gallagher studied at University of Michigan (Ph.D., M.S.); University of Massachusetts Amherst (B.S., Chemistry).
Same school
Also attended University of Michigan811
Erik TorenbergGeneral Partner at Andreessen Horowitz; founder of TurpentineGlen AndersonPartner at Monta Vista CapitalAlexandra FarmerPrincipal at Intel Capital, North AmericaScott ShawChief of Staff at Intel CapitalZach PoleyPartner and Chief Technology Officer at Clear VenturesTom DanilekPartner, Rise of the Rest Real Estate at Revolution
+ 805 more
Also attended University of Massachusetts Amherst196
Larry BohnInvestment Team at General CatalystQuentin ClarkInvestment Team at General CatalystRavi RajamonyVice President at March Capital PartnersJason MorrisVice President, Investor Relations at Sapphire VenturesRobert SeveroPartner, Chief Compliance Officer at Sapphire VenturesJonathan BavaroAccounting Manager at Founder Collective
+ 190 more
Shared employers
Also worked at Nimbus Therapeutics8
Erin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesVikas GoyalPartner at Longwood FundNikolaInvestment Committee Member at ACF InvestorsNikola TrbovicManaging Partner at SV Health InvestorsAlex Badamchi-ZadehVice President at SV Health Investors
+ 2 more
Also worked at SR One32
Freya Svedberg-KeatingInvestor at MedicxiJake BauerVenture Partner at ARCH Venture PartnersAleks Radovic-MorenoPartner at Longwood FundVikas GoyalPartner at Longwood FundSimeon J. GeorgeFounder & CEO at SR One Capital ManagementRajeev DadooCOO & Managing Partner at SR One Capital Management
+ 26 more
Also worked at GlaxoSmithKline174
Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Victoria TaylorInvestor at MedicxiErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesJane SuhPrincipal on the AlleyCorp Healthcare teamCarol SuhPartner at ARCH Venture Partners
+ 168 more
